Magne Henriksen
Overview
Explore the profile of Magne Henriksen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
1058
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lund C, Strande V, Hagen M, Bengtson M, Boyar R, Detlie T, et al.
Inflamm Bowel Dis
. 2024 Dec;
PMID: 39699202
Background And Aims: The emergence of biologic therapy has coincided with a decline in surgery rates for Crohn's disease (CD). This study aims to describe the disease course, including intra-abdominal...
2.
Holten K, Bernklev T, Opheim R, Olsen B, Detlie T, Strande V, et al.
J Crohns Colitis
. 2024 Nov;
PMID: 39527064
Background And Aims: Fatigue is commonly observed in Crohn's disease (CD) and ulcerative colitis (UC), but its association to achieving remission is not clearly established. In this study we describe...
3.
Strande V, Lund C, Hagen M, Bengtson M, Cetinkaya R, Detlie T, et al.
Aliment Pharmacol Ther
. 2024 Jun;
60(3):357-368.
PMID: 38837289
Background: The introduction of biologic therapies and the 'treat-to-target' treatment strategy may have changed the disease course of ulcerative colitis (UC). Aims: To describe the early disease course and disease...
4.
Aass Holten K, Bernklev T, Opheim R, Johansen I, Olsen B, Lund C, et al.
J Crohns Colitis
. 2023 Jun;
17(11):1781-1790.
PMID: 37279652
Background And Aims: Although fatigue is common in inflammatory bowel disease [IBD], its pathogenesis remains unclear. This study aimed to determine the prevalence of fatigue and its associated factors in...
5.
Lerang F, Holst R, Henriksen M, Wahlberg H, Jelsness-Jorgensen L
Scand J Gastroenterol
. 2022 Feb;
57(8):921-929.
PMID: 35188443
Objectives: To examine the long-term efficacy and side effects of antitumour necrosis factor alpha (anti-TNF) therapy in patients with Crohn's disease (CD), the need for surgery and the clinical outcome...
6.
Kristensen V, Opheim R, Perminow G, Huppertz-Hauss G, Detlie T, Lund C, et al.
Scand J Gastroenterol
. 2021 Jun;
56(8):899-905.
PMID: 34154494
Background And Aim: Modern treatment strategies for inflammatory bowel disease (IBD) are postulated to change the natural disease course. Inception cohort studies are the gold standard for investigating such changes....
7.
Monstad I, Solberg I, Cvancarova M, Hovde O, Henriksen M, Huppertz-Hauss G, et al.
J Crohns Colitis
. 2020 Dec;
15(6):969-979.
PMID: 33367569
Background And Aims: The long-term course of ulcerative colitis [UC] is difficult to predict. Mortality, colectomy, cancer, and hospitalisation represent hard outcomes of disease. Moreover, knowledge on the risk of...
8.
Jorgensen K, Goll G, Sexton J, Bolstad N, Olsen I, Asak O, et al.
BioDrugs
. 2020 Sep;
34(5):681-694.
PMID: 32965617
Background: The NOR-SWITCH main and extension trials demonstrated that switching from originator to biosimilar infliximab (CT-P13) is efficacious and safe across six diseases. However, a subgroup analysis of Crohn's disease...
9.
Klepp P, Brackmann S, Cvancarova M, Hoivik M, Hovde O, Henriksen M, et al.
BMJ Open Gastroenterol
. 2020 Apr;
7(1):e000361.
PMID: 32337058
Objective: The association between ulcerative colitis (UC) and colorectal cancer (CRC) is widely accepted, although attenuated risk has been reported in recent years. Colonoscopic surveillance is recommended with intervals based...
10.
Henriksen M, Hoivik M, Jelsness-Jorgensen L, Moum B
J Crohns Colitis
. 2017 Nov;
12(4):389-393.
PMID: 29186372
Background And Aims: An increased prevalence of irritable bowel syndrome [IBS]-like symptoms has been reported in patients with ulcerative colitis [UC]. Whether ongoing inflammation increases the prevalence of such symptoms...